Peter Trillenberg
Overview
Explore the profile of Peter Trillenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sondermann S, Boppel T, Fieseler K, Schramm P, Baumer T, Trillenberg P
Muscle Nerve
. 2024 Feb;
69(4):409-415.
PMID: 38323736
Introduction: Magnetic resonance neurography (MRN) and myography (MRM) are emerging imaging methods for detecting diseases of the peripheral nerve system (PNS). Most patients with PNS diseases also undergo needle electromyography...
2.
Rieken S, Kronziel L, Langer T, Rades D, Boppel T, Trillenberg P, et al.
J Cancer Res Clin Oncol
. 2023 Nov;
149(20):17865-17879.
PMID: 37947868
Purpose: To prospectively assess the incidence of Dropped Head Syndrome (DHS) in childhood cancer survivors (CCS) and to develop and evaluate a diagnostic algorithm for DHS. Methods: A systematic literature...
3.
Zemskova O, Yu N, Trillenberg P, Bonsanto M, Leppert J, Rades D
Anticancer Res
. 2023 May;
43(6):2725-2732.
PMID: 37247904
Background/aim: Standard radiotherapy (RT) for glioblastoma lasts 6 weeks. We aimed to identify patients who would benefit from a hypofractionated approach. Patients And Methods: In 167 patients receiving standard fractionation,...
4.
Rades D, Al-Salool A, Yu N, Trillenberg P, Bonsanto M, Leppert J
In Vivo
. 2023 Apr;
37(3):1198-1204.
PMID: 37103101
Background/aim: A recommendation of radiotherapy for patients with malignant gliomas may trigger emotional distress. Frequency and risk factors of this complication were investigated. Patients And Methods: Prevalence of six emotional...
5.
Trillenberg P, Sprenger A, Machner B
Pharmacoepidemiol Drug Saf
. 2023 Mar;
32(8):910-917.
PMID: 36966482
Purpose: As measures of association between an adverse drug reaction (ADR) and exposure to a drug the reporting odds ratio (ROR) and the information component (IC) can be used. We...
6.
Rades D, Witteler J, Trillenberg P, Olbrich D, Schild S, Tvilsted S, et al.
In Vivo
. 2022 Sep;
36(5):2308-2313.
PMID: 36099095
Background/aim: Little is known regarding seizures during radiotherapy for brain tumors. This prospective study investigated seizure activity in patients irradiated for high-grade gliomas. Patients And Methods: Using a seizure diary,...
7.
8.
Machner B, Erber K, Choi J, Sprenger A, Helmchen C, Trillenberg P
Front Neurol
. 2021 Nov;
12:741859.
PMID: 34777209
The head impulse test (HIT) assesses the vestibulo-ocular reflex (VOR) and is used to differentiate vestibular neuritis (abnormal VOR) from stroke (normal VOR) in patients presenting with an acute vestibular...
9.
The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency
Trillenberg P, Katalinic A, Thern J, Graf T
Eur J Neurol
. 2021 Jun;
28(9):2965-2970.
PMID: 34184370
Background And Purpose: Some groups of cardiovascular drugs (beta-blocking drugs, Ca antagonists, antiarrhythmics) are listed as potentially worsening myasthenia. An empirical basis for alternative recommendations for antihypertensive and antiarrhythmic therapy...
10.
Rades D, Witteler J, Olbrich D, Trillenberg P, Schild S, Tvilsted S, et al.
BMC Cancer
. 2021 Apr;
21(1):386.
PMID: 33836671
Background: Gliomas are often associated with symptoms including seizures. Most patients with high-grade gliomas are treated with radiotherapy or radio-chemotherapy. Since irradiation causes inflammation, it may initially aggravate symptoms. Studies...